Oxygen Concentration Target in Stroke Endovascular Treatment - Trial NCT06224426
Access comprehensive clinical trial information for NCT06224426 through Pure Global AI's free database. This phase not specified trial is sponsored by Beijing Tiantan Hospital and is currently Recruiting. The study focuses on Ischemic Stroke. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Beijing Tiantan Hospital
Timeline & Enrollment
N/A
Feb 01, 2024
Dec 31, 2026
Primary Outcome
the incidence of early neurological improvement (ENI)
Summary
The goal of this clinical trial is to compare the effects of different concentrations of
 normobaric oxygen on early neurological improvement in acute ischemic stroke (AIS) patients
 receiving endovascular therapy (EVT). The main questions it aims to answer are:
 
 - Evaluating the impact of normobaric high-concentration oxygen versus low-concentration
 oxygen on early neurological function after EVT.
 
 - Evaluating the safety of high and low normobaric oxygen concentration in patients with
 ischemic stroke.
 
 Participants will (1) receive EVT under general anesthesia; (2) be randomly assigned 1:1 to
 receive oxygen therapy with FiO2=80% or FiO2=30% through endotracheal intubation during the
 operation, and the gas flow rate was set at 4L /min.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06224426
Non-Device Trial